Saturday 7 November 2026
Export AHR’s income statement to Excel — free account
American Healthcare REIT, Inc.
AHR Real Estate Reit Healthcare Facilities
American Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 9.15% from fiscal 2024.
- Revenue
- +29.5%
- EPS
- −57.6%
- Free cash flow
- +9.53%
- Total debt
- −64.6%
Quarter to September 2026, against a year earlier
57.92
1.88
+3.35%
Follow AHR
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
104.61 | 76.69 | 81.31 | 114.78 |
+8 more quarters Free account |
P/S ratio |
4.16 | 4.02 | 3.73 | 3.46 | |
P/FCF ratio |
40.21 | 46.39 | 42.10 | 36.16 | |
P/Operating CF |
66.58 | 84.72 | 108.97 | 141.66 | |
P/B ratio |
1.99 | 2.69 | 2.51 | 2.33 | |
Price to Tangible BV |
2.23 | 3.07 | 2.91 | 2.72 | |
EV/Sales |
4.60 | 4.52 | 4.31 | 4.08 | |
EV/EBITDA |
27.93 | 25.67 | 24.67 | 23.69 | |
EV/Operating CF |
29.16 | 31.21 | 32.47 | 31.29 | |
EV/FCF |
44.50 | 52.16 | 48.72 | 42.64 | |
Quick Ratio |
0.53 | 0.48 | 0.45 | 0.41 | |
Current Ratio |
0.53 | 0.48 | 0.45 | 0.41 | |
Net Debt/EBITDA |
0.00 | 10.12 | 12.09 | 13.90 | |
Debt/Assets |
7.23% | 25.29% | 27.61% | 28.58% | |
Debt/Equity |
0.10 | 0.39 | 0.44 | 0.46 | |
Asset Turnover |
0.43 | 0.49 | 0.47 | 0.46 | |
Operating CF/Net income |
5.35 | 3.88 | 3.42 | 5.12 | |
Capex/Depreciation |
— | (0.50) | (0.50) | (0.69) | |
Interest Coverage |
2.64 | 2.32 | 2.25 | 1.86 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.91% | 2.95% | 2.71% | 2.74% | |
Intangible Assets out of Total Assets |
0.08 | 0.08 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
1.25% | 0.86% | 0.75% | 0.90% | |
Graham Net Nets |
(0.14) | (0.15) | (0.19) | (0.22) | |
Graham Number |
16.85 | 17.24 | 15.66 | 13.66 | |
Earnings Yield |
0.96% | 1.30% | 1.23% | 0.87% | |
Free Cash Flow Yield |
2.49% | 2.16% | 2.38% | 2.77% | |
Revenue per Share |
3.42 | 3.50 | 3.47 | 3.64 | |
Operating CF per Share |
0.77 | 0.62 | 0.43 | 0.33 | |
Capex per Share |
0.00 | (0.21) | (0.20) | (0.27) | |
Free Cash Flow per Share |
0.77 | 0.41 | 0.23 | 0.06 | |
Cash per Share |
1.19 | 0.99 | 0.84 | 0.91 | |
Shareholders Equity per Share |
25.75 | 19.42 | 18.80 | 20.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
25.75 | 19.42 | 18.80 | 20.24 | |
Free Cash Flow |
166.89 | 78.24 | 42.75 | 10.66 | |
Working Capital |
(434.87) | (460.76) | (491.60) | (511.44) | |
Capital Expenditures |
— | (40.38) | (38.32) | (44.50) | |
Net Current Asset Value |
(1,539.53) | (1,540.77) | (1,678.82) | (1,709.54) | |
EV/EBIT |
74.54 | 70.54 | 62.26 | 56.26 | |
Capex to Sales |
0.00 | 0.06 | 0.06 | 0.07 | |
Price to Operating Income |
67.36 | 62.73 | 53.80 | 47.72 | |
| Other line items | |||||
Average Receivables |
208.55 | 226.85 | 232.13 | 207.71 | |
Average Payables |
335.09 | 302.92 | 306.27 | 288.03 | |
Average Assets |
6,189.82 | 5,105.28 | 5,031.35 | 4,957.14 | |
Average Common Equity |
4,151.29 | 3,102.27 | 2,912.92 | 2,832.28 |
Columns are period end dates · fundamentals updated 6 Nov 2026